SCHEMBL20182064

SCHEMBL20182064

c1ccc2c(c1)-c1ccccc1C21c2ccccc2-c2c(Nc3cccc4oc5ccccc5c34)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
PDK2 Q15119 1/20 0.33
MAOA P21397 2/20 0.31
MAPT P10636 4/20 0.31
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
OPRK1 P41145 1/20 0.31
HPGD P15428 3/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
PGAM1 P18669 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
GAA P10253 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20181982 0.99 CYP1A2 (0.33) CYP1A2SMN1; SMN2ALDH1A1LMNAPDK2
SCHEMBL26687595 0.91 CYP1A2 (0.31) CYP1A2SMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL21094725 0.91 LMNA (0.35) CYP1A2SMN1; SMN2ALDH1A1LMNAPDK2
SCHEMBL15840193 0.88 PDK2 (0.34) CYP1A2PDK2AHR
SCHEMBL23372696 0.86 ALDH1A1 (0.34) CYP1A2SMN1; SMN2ALDH1A1LMNAMAOA
SCHEMBL18647428 0.85 ALOX5 (0.38) CYP1A2SMN1; SMN2ALDH1A1LMNAPDK2
SCHEMBL21094689 0.85 ALDH1A1 (0.35) CYP1A2SMN1; SMN2ALDH1A1LMNAPDK2
SCHEMBL21615073 0.84 CYP1A2 (0.38) CYP1A2SMN1; SMN2ALDH1A1LMNAPDK2
SCHEMBL23423964 0.83 MEN1 (0.31) SMN1; SMN2ALDH1A1LMNAMAPTMEN1
SCHEMBL21665494 0.82 PDK2 (0.42) CYP1A2SMN1; SMN2LMNAPDK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189639-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230189639-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20220119373-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-04-21 US disclosed
US-10961230-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2021-03-30 US disclosed
EP-3541890-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-10-28 EP disclosed
EP-3423542-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-07-22 EP disclosed
US-20190352318-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-11-21 US disclosed
US-20190119260-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-04-25 US disclosed
US-20190088878-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-03-21 US disclosed
WO-2018091435-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189639-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF ETV6, OR51E2, NFE2L2 CYP1A2 2529/4885SMN1; SMN2 917/4885ALDH1A1 1423/4885
US-10961230-B2 Materials for organic electroluminescent devices DDT, PNMT, INMT CYP1A2 1398/4885SMN1; SMN2 4578/4885ALDH1A1 560/4885
US-20190088878-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, PNMT, ESD CYP1A2 2385/4885SMN1; SMN2 3757/4885ALDH1A1 734/4885
US-20220119373-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, PNMT, ESD CYP1A2 2385/4885SMN1; SMN2 3757/4885ALDH1A1 734/4885
US-20190352318-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, EFNA1, EPCAM CYP1A2 441/4885SMN1; SMN2 2476/4885ALDH1A1 33/4885
US-20190119260-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, PNMT, INMT CYP1A2 1398/4885SMN1; SMN2 4578/4885ALDH1A1 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.